Soleus Private Equity Fund III, L.P. 13D and 13G filings for CalciMedica, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:00 pm Sale | 2025-09-30 | 13G | CalciMedica, Inc. CALC | Soleus Private Equity Fund III, L.P. | 1,075,856 7.500% | -100,000 (-8.50%) | Filing |
| 2024-11-14 3:32 pm Purchase | 2024-09-30 | 13G | CalciMedica, Inc. CALC | Soleus Private Equity Fund III, L.P. | 1,175,856 8.500% | 1,175,856 (New Position) | Filing |